Protein C and the Development of Skin Necrosis During Anticoagulant Therapy

A W Broekmans; R M Bertina; E A Loeliger; V Hofmann; H-G Klingemann

doi:10.1055/s-0038-1657378

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1983; 49(03): 251
DOI: 10.1055/s-0038-1657378

Letter to the Editor

Schattauer GmbH Stuttgart

Protein C and the Development of Skin Necrosis During Anticoagulant Therapy

A W Broekmans

Haemostasis and Thrombosis Research Unit, Leiden University Hospital, Leiden, The Netherlands

,

R M Bertina

Haemostasis and Thrombosis Research Unit, Leiden University Hospital, Leiden, The Netherlands

,

E A Loeliger

Haemostasis and Thrombosis Research Unit, Leiden University Hospital, Leiden, The Netherlands

,

V Hofmann

¹Department of Internal Medicine, University Hospital Zürich, Switzerland

,

H-G Klingemann

²The Department of Internal Medicine, University Hospital, Marburg, West-Germany

› Author Affiliations

Abstract

PDF Download

PDF (328 kb)

References

References
1 Van Amstel WJ, Boekhout-Mussert MJ, Loeliger EA. Successful prevention of coumarin-induced hemorrhagic skin necrosis by timely administration of vitamin Kj. Blut 1978; 36: 89-93
2 Boss JM, Summerly R. Prevention of warfarin-induced skin necrosis. Br J Dermatol 1979; 100: 617
3 Hoffmann V, Frick PG. Repeated occurrence of skin necrosis twice following coumarin intake and subsequently during decrease of vitamin K dependent coagulation factors associated with cholestasis. Thromb Haemostas 1982; 48: 245-246
4 Stenflo J. A new vitamin K dependent prote. purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-363
5 Nesheim ME, Canfield WM, Kisiel W, Mann KG. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-1447
6 Marlar RA, Kleiss AJ, Griffin JH. Human protein C: inactivation of factor V and VIII in plasma by the activated molecule. Ann NY Acad Sci 1981; 370: 303-310
7 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
8 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1980; 68: 1370-1373
9 Bertina RM, Broekmans AW, Van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
10 Klingemann H-G, Egbring R. Die Kumarinnekrose. Med Welt 1982; 33: 676-677
11 Owen WG. The control of haemostasis; role of endothelium in the regulation of inhibitory and catabolic pathways. Arch Pathol Lab Med 1982; 106: 209-213